Current Oncology Reports

Papers
(The TQCC of Current Oncology Reports is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review137
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain135
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer89
New Developments in VHL-Associated Neuroendocrine Neoplasms89
Management of Upper Tract Urothelial Carcinoma83
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications74
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances70
Brain Prehabilitation for Oncologic Surgery66
Immunotherapy in Biliary Tract Cancers: Where Are We?58
NRG1 Fusions: The New Kid on the Block54
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review51
New Insights on Tramadol and Immunomodulation50
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas43
Treatment of Metastatic Melanoma in the Elderly41
Fatty Acid Metabolism and Cancer Immunotherapy41
Surgical Management of Melanoma: Advances and Updates37
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers37
Prostate Cancer Immunotherapy—Finally in From the Cold?35
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors35
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting35
Management of In-Transit Metastases35
Current Trends and Challenges of Microbiome Research in Prostate Cancer35
An Overview of Angiogenesis in Bladder Cancer34
Head and Neck Mucosal Melanoma: Where Are We Now?32
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites31
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan31
Surgical Stress and Cancer Progression: New Findings and Future Perspectives31
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients31
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications31
Cellular Therapy in NSCLC: Between Myth and Reality31
Anti-PD-1: When to Stop Treatment30
The Microbiome in Advanced Melanoma: Where Are We Now?29
Engineered T Cells: CAR T Cell Therapy and Beyond28
The Difficult Airway in Patients with Cancer28
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?27
AXL Inhibitors: Status of Clinical Development27
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients27
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review26
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours25
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations25
Cancer Pain Management—New Therapies25
CAR-T Therapies in Solid Tumors: Opportunities and Challenges24
Targeting the PI3K Pathway in Gynecologic Malignancies24
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy24
Proton Therapy in The Treatment of Head And Neck Cancers- Review24
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors24
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?24
Appendiceal Neuroendocrine Neoplasms: an Update for 202324
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations23
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews23
Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases23
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question23
Surgery for Recurrent Epithelial Ovarian Cancer22
Geographical Disparities in Colorectal Cancer in Canada: A Review22
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma22
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review21
Development of Effective Siglec-9 Antibodies Against Cancer21
Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies21
Helping Patients Understand and Cope with BRCA Mutations21
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer21
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)20
Vascular Inflammation, Cancer, and Cardiovascular Diseases20
Critical Review of the Current Evidence on Sentinel Node Biopsy in Oral Cancer20
Current Management of Neuroendocrine Tumour Liver Metastases20
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials20
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions20
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing20
Evolving Treatment Approaches to Mucosal Melanoma19
Elderly Rectal Cancer: An Updated Review19
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging19
Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia19
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets18
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction18
Small Cell and Other Rare Histologic Types of Cervical Cancer18
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?18
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity17
Current Diagnostic Tools for Breast Cancer-Related Lymphedema17
Rehabilitation in Advanced Cancer Patients with Bone Metastases and Neural Compromise: Current Status and Future Directions17
Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management17
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic17
Management of Peripheral T-cell Lymphomas and the Role of Transplant17
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer17
Ependymoma: Evaluation and Management Updates17
Multimodality Therapies for Localized Prostate Cancer16
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review16
Current Status on Management of Primary Plasma Cell Leukemia16
Intratumoral Immunotherapy: Is It Ready for Prime Time?16
History of Leukemia, Revisited16
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review16
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights16
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review16
Epidemiology of Cancer in Older Adults: A Systematic Review15
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers15
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy15
Statins for Cardiac and Vascular Protection During and After Cancer Therapy15
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives15
The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities15
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours14
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment14
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment14
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis14
Richter’s Transformation14
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade14
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma14
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge14
Return to Intended Oncological Therapy: State of the Art and Perspectives14
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy14
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions14
Bystander effect of antibody–drug conjugates: fact or fiction?13
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?13
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer13
Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies13
Viral and Clinical Oncology of Head and Neck Cancers13
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL13
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development13
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas13
Carbon Ion Radiotherapy in the Head and Neck Cancers Treatment and its Potential Role in Personalized Treatment Approach– A Review of the Current Knowledge13
Interventional Strategies in Cancer-induced Cardiovascular Disease12
Racial Disparities in Breast Cancer: from Detection to Treatment12
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer12
Current Role of Functional Imaging in the Management of Lymphoma12
CDK4/6 inhibitors: The Devil is in the Detail12
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations12
Clinicopathological Review of Micropapillary Urothelial Carcinoma12
Correction to: Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review12
Approaches to Non-Muscle-Invasive Bladder Cancer12
The Role and Impact of Minimal Residual Disease in NSCLC12
Is Myelodysplasia a Consequence of Normal Aging?12
Lymphatic Interventions in the Cancer Patient12
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis11
CAR T-cell Therapy for Central Nervous System Lymphoma11
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine11
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan11
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer11
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer11
Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity11
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab11
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer11
Navigating the Cancer Screening Decision for Patients with Dementia11
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science11
Surviving Burnout as an Oncologist11
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes11
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment11
Advances in Treatment of Waldenström Macroglobulinemia11
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway11
Cardio-Oncology in Childhood: State of the Art11
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers11
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism11
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes11
0.17579412460327